MD3 CHANGES IN BODYWEIGHT AND ASSOCIATED DOSING REQUIREMENTS FOR RHEUMATOID ARTHRITIS PATIENTS RECEIVING INFLIXIMAB—RESULTS FROM ANALYSIS OFTHE BRITISH SOCETY FOR RHEUMATOLOGY'S BIOLOGICS REGISTER (BSRBR)

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64898-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64898-X/fulltext
Title : MD3 CHANGES IN BODYWEIGHT AND ASSOCIATED DOSING REQUIREMENTS FOR RHEUMATOID ARTHRITIS PATIENTS RECEIVING INFLIXIMAB—RESULTS FROM ANALYSIS OFTHE BRITISH SOCETY FOR RHEUMATOLOGY'S BIOLOGICS REGISTER (BSRBR)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64898-X&doi=10.1016/S1098-3015(10)64898-X
First page :
Section Title :
Open access? : No
Section Order : 57
Categories :
Tags :
Regions :
ViH Article Tags :